Third, therapies to prevent thrombotic complications, such as low‐dose aspirin used routinely in many ET patients to reduce microvascular symptoms and clot risk, can tip the balance toward bleeding if an acquired VWF or platelet dysfunction is present. Here, VWF is linked to essential thrombocythemia.